Progressive supranuclear palsy (PSP) causes profound and irreversible damage to the brain, often before a diagnosis is even ...

Summary: New research uncovers how tau pathology spreads and damages synapses in progressive supranuclear palsy (PSP). Using ...

FNP-223, previously known as ASN90, is a reversible and substrate-competitive O-GlcNAcase enzyme inhibitor. The oral investigational drug is expected to rapidly increase O-GlcNAcylated tau proteins, ...

“When she would fall in public, people just assumed she was drunk,” said Glenn. “One time she fell backwards on the steps and ...

We were fortunate to have the resources to travel to Portland, Oregon to access medical aid in dying. Thousands of New York ...

The FDA approved an expanded access program for troculeucel, making the treatment available to patients outside clinical trials.

Ali worked actively with Michael J. Fox on Parkinson's advocacy, also partnering with the Michael J. Fox Foundation. Reports ...

Commercial real estate player and former Kislak President Jeffrey Wiener died July 9 after a long battle with progressive ...

Researchers from Asan Medical Center, one of South Korea's largest hospitals, have developed a generative AI model that can ...

So, let’s talk about faith. I’m no rabbi or scholar, and I’m not trying to write a religious work. But putting my thoughts ...

Troculeucel, a cryopreserved, autologous enhanced natural killer cell therapy, has demonstrated preliminary clinical benefit without any drug-related adverse events in two Phase I clinical trials in ...

TPN-101, a potent nucleoside reverse transcriptase inhibitor that specifically inhibits the LINE-1 reverse transcriptase.